Clinical trials
Screening clinical trials
Below are recruiting screening clinical trials, each written for real people, not researchers. We’re tracking 922 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06428643Recruiting
Chlamydia prevention program for young Black adults in New Orleans
This study tests a program to help reduce chlamydia infections in young Black or African American people in New Orleans. It involves testing for chlamydia and then providing treatment or prevention support.
New Orleans, LouisianaAges 15–26 - NCT06404970Recruiting
A study for older veterans with frailty in primary care
This study aims to help identify and manage functional impairment and frailty in older veterans. It will test ways to improve how primary care providers screen and support veterans who may have difficulty with daily activities or overall health declines.
Philadelphia, PennsylvaniaAges 60 years+ - NCT06403423Enrolling by invitation
Screening for aortic aneurysms in Inland Norway
This trial invites all men in Inland Norway to get screened for aortic aneurysms, a bulge in the main artery that can be dangerous if not found early. The screening is a simple, painless ultrasound to check for this condition.
Hamar, HamarAges 65–65 - NCT06412029Enrolling by invitation
Improving social needs screening in community cancer clinics
This study aims to help community cancer clinics find better ways to ask patients about their social needs, like food, housing, or transportation. Researchers will work with clinic staff and patients to improve how these screenings happen.
Newark, DelawareAges 18 years+ - NCT06181162Recruiting
YoPA: A youth-led program for better health
This study tests a program called YoPA, created with and for young people, to help improve health and well-being. It focuses on teenagers living in disadvantaged areas and aims to see if a youth-led approach can make a positive difference.
OdenseAges 12–18 - NCT06398457RecruitingEarly Phase 1
Darzalex Before Stem Cell Transplant for High-Risk Graft Failure
This trial tests giving a drug called Darzalex Faspro before the usual desensitization and a stem cell transplant for people at high risk of graft failure due to donor-specific antibodies. The goal is to prevent the transplant from failing.
Baltimore, MarylandAges 18 years+ - NCT06376097Recruiting
Lung cancer screening with low-dose CT and a blood test
This study tests a lung cancer screening program using low-dose CT scans and a blood test to find cancer early. It is for people who smoke or used to smoke.
Botucatu, São PauloAges 45–74 - NCT06360822Recruiting
Making lung cancer screening fair for everyone
This trial is testing a program to make lung cancer screening more fair and available. If you're eligible, you may be offered a free or low-cost screening to check for lung cancer early, which could improve treatment options.
Indianapolis, IndianaAges 50–80 - NCT06370520Recruiting
Teen emotions screening after mild brain injury
This study screens teens aged 11 to 17 for emotional and mental health problems after a mild traumatic brain injury (mTBI, also called concussion or minor head injury). The goal is to find out if the hospital screening helps identify teens who may need extra support.
Sacramento, CaliforniaAges 11–17 - NCT04724941Recruiting
Screening for alpha-synuclein in early Parkinson’s risk
This study looks for changes in a protein called alpha-synuclein in people who may be in the early “prodromal” stage before Parkinson’s symptoms fully appear. It may help researchers find early markers and understand who is more likely to develop Parkinson’s disease.
KielAges 50–99 - NCT05606133Recruiting
Test HPV DNA from blood to track cervical cancer risk
This study looks at a blood test that measures HPV DNA to help screen and monitor people with HPV-related cervical problems. If you have confirmed high-grade cervical changes or cervical cancer, the test may help doctors follow how your condition changes over time.
New York, New YorkAges 18 years+ - NCT06330441Recruiting
Pancreatic cancer screening for high-risk groups
This study screens people at high risk for pancreatic cancer using imaging tests. It aims to catch cancer early in those with certain genetic conditions or strong family history.
BrnoAges 18 years+ - NCT06330480Enrolling by invitation
Screening for heart rhythm and kidney disease at home
This study is testing whether screening people at home can catch early signs of an irregular heartbeat (atrial fibrillation) and kidney disease. If you're in the right age group and live in one of the selected regions, you could join and help researchers learn more about spotting these conditions early.
AmsterdamAges 50–75 - NCT06324110Enrolling by invitation
Lung cancer screening follow-up study
This study is testing whether a centralized support program helps people get regular lung cancer screening. If you are at risk for lung cancer and have had a screening CT scan at one of the participating health centers, this study may help improve care.
Seattle, WashingtonAges 18 years+ - NCT06311214RecruitingPhase 2
Personalized ADC therapy for advanced solid tumors
This trial tests personalized antibody-drug conjugates (ADCs) for advanced solid tumors. It looks for specific proteins on your tumor cells to match you with a treatment that targets them directly.
Duarte, CaliforniaAges 18 years+ - NCT06314334RecruitingPhase 2
Chemotherapy plus radiation for early-stage NK/T-cell lymphoma
This trial tests whether combining chemotherapy with radiation therapy can work well for people with early-stage NK/T-cell lymphoma that started in the nose or throat. It aims to find a more effective treatment approach with fewer side effects.
Fuzhou, FujianAges 18–75 - NCT06314022Recruiting
Mobile app for better colonoscopy in cancer screening
This study tests a mobile app designed to help improve the quality of colonoscopies for people in a colorectal cancer screening program. If you have had a positive FIT test and are between 50 and 69, you may be able to join.
Valladolid, ValladolidAges 50–74 - NCT06295497Recruiting
Lung cancer screening for non-smokers with a family history
This study tests an artificial intelligence device to screen for lung cancer in people who have never smoked but have a close family member with lung cancer. If you are between 50 and 75 and fit for possible surgery, you may be able to join.
Hong KongAges 50–75 - NCT06305676Recruiting
A study for early detection of HPV throat cancer
This study looks for early signs of HPV-related throat cancer. If you've just been diagnosed and haven't started treatment, your blood or saliva samples may help improve future screening tests.
Tampa, FloridaAges 18 years+ - NCT06291896Recruiting
Testing microwave imaging for breast cancer screening
This study tests a new, safe microwave-based device (MammoWave) to screen for breast cancer. It compares the device's results with standard mammograms to see if it can find cancer early in women at average risk.
Genova, GenovaAges 45–74 - NCT06289348Recruiting
How is PKU announced to families after newborn screening?
This study talks to parents or doctors about how they first learned their child had PKU through newborn screening. It aims to improve how these rare metabolic diseases are communicated to families.
ParisAges 18 years+ - NCT06268405Recruiting
PET scan and blood test for high-risk breast screening
This study tests a new PET scan machine for the breast (positron emission mammography) along with a blood test called a liquid biopsy for women who need a biopsy after a high-risk breast screening. It may help find cancer more accurately and less invasively.
Toronto, OntarioAges 18 years+ - NCT06269744Enrolling by invitation
Proactive outreach with stool test for colorectal cancer screening
This study reaches out to adults aged 45–75 who are due for colorectal cancer screening. It uses a simple stool test (FIT) to help find cancer early and is offered at certain NYU Langone clinics.
Brooklyn, New YorkAges 45–75 - NCT06254846Recruiting
Urine test for HPV cervical cancer screening
This study tests if a urine sample can replace a cervical swab for HPV testing during cervical cancer screening. If it works, it could make screening easier and less uncomfortable.
Saint-EtienneAges 30–65
Hear when a new Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for screening?
- Yes. Clin2 currently lists 922 recruiting screening studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a screening trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a screening trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.